'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Human Papillomavirus Infections Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Human Papillomavirus Infections 30
Dec 13, 2016: Genticel Reports Final Results of GTL001 Phase 2 Trial in HPV16/18-Infected Women 30
Clinical Trial Profile Snapshots 31
Appendix 247
Abbreviations 247
Definitions 247
Research Methodology 248
Secondary Research 248
About GlobalData 249
Contact Us 249
Disclaimer 249
Source 250
List of Tables
Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Region, 2016* 6
Human Papillomavirus Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Human Papillomavirus Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Human Papillomavirus Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Human Papillomavirus Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Human Papillomavirus Infections Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Human Papillomavirus Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
Human Papillomavirus Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
Human Papillomavirus Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Human Papillomavirus Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
Human Papillomavirus Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Human Papillomavirus Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Human Papillomavirus Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Human Papillomavirus Infections Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Human Papillomavirus Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
List of Figures
Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Human Papillomavirus Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Human Papillomavirus Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Human Papillomavirus Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Human Papillomavirus Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Human Papillomavirus Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Human Papillomavirus Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
Human Papillomavirus Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
Human Papillomavirus Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Human Papillomavirus Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
Human Papillomavirus Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Human Papillomavirus Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Human Papillomavirus Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Human Papillomavirus Infections Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Human Papillomavirus Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
GlobalData Methodology 248